1. Introduction

The Biological Inheritance Doctrine Governance is a legal and ethical framework for regulating how biological characteristics, genetic information, inherited diseases, reproductive decisions, and hereditary materials affect individual rights, family relationships, public institutions, and future generations.

The expression is not, by itself, a universally recognized, formally codified legal doctrine. Rather, it can be understood as an interdisciplinary framework developed from constitutional law, human rights, genetics regulation, medical law, family law, privacy law, and anti-discrimination principles.

The central question is:

How should the law govern the transmission, use, interpretation, and regulation of inherited biological characteristics without undermining human dignity, equality, autonomy, and the rights of future generations?

For example, legal problems may arise when an employer discriminates against a person because of a hereditary disease risk, an insurer uses genetic information to determine eligibility, a government restricts reproductive choices on hereditary grounds, or a biotechnology company uses genetic materials without adequate consent.

Biological inheritance governance seeks to establish safeguards against these forms of genetic discrimination, coercion, exploitation, and misuse of biological information.

2. Meaning and scope of the doctrine

The framework has six principal dimensions.

1. Genetic inheritance and identity

Determines how inherited genetic characteristics may be used in medicine, research, identity verification, and legal proceedings while protecting privacy and dignity.

2. Equality and non-discrimination

Prevents unfair treatment based on inherited disease risks, genetic variations, ancestry-related assumptions, or presumed biological disadvantages.

3. Reproductive autonomy

Protects decisions concerning genetic testing, reproductive counselling, prenatal diagnosis, assisted reproduction, and reproductive treatment.

4. Intergenerational responsibility

Addresses the long-term consequences of heritable genome editing, genetic interventions, and the transmission of biological risks to future generations.

5. Institutional accountability

Regulates the conduct of hospitals, laboratories, researchers, biotechnology companies, insurers, employers, and public authorities.

6. Biological inheritance and social justice

Examines how inherited characteristics interact with poverty, disability, access to healthcare, education, and social inequality.

These dimensions are interconnected. Genetic information may be medically relevant, but its usefulness does not automatically justify unrestricted collection, disclosure, or discriminatory use.

3. Foundational principles of biological inheritance governance

A. Human dignity and genetic uniqueness

A person's genetic composition must not become the sole basis for determining their social worth, legal status, employment opportunities, or entitlement to public services.

Article 2 of UNESCO's Universal Declaration on the Human Genome and Human Rights states that dignity and rights must be respected regardless of genetic characteristics. Article 5 addresses prior, free, and informed consent for research, treatment, or diagnosis affecting an individual's genome. The Declaration is an important international ethical instrument, although it is not itself a directly enforceable domestic statute in every country.

UNESCO

+1

Governance implication: Genetic information may inform healthcare decisions, but it should not be used to reduce a person to a presumed hereditary condition.

B. Genetic privacy and informed consent

Genetic information can reveal facts about more than one person. A genetic test may disclose a patient's inherited disease risk while also revealing information about biological relatives.

A sound governance framework should therefore address:

Informed consent before genetic testing and secondary research use.

Secure storage and restricted access to genetic databases.

Limits on disclosure to employers, insurers, relatives, or government agencies.

Clear rules for retaining and deleting biological samples.

Procedures for handling incidental findings and medically significant hereditary risks.

The legal challenge is balancing individual confidentiality against justified interests in preventing serious harm. A relative's possible interest in receiving health information does not automatically eliminate the tested person's privacy rights.

C. Equality and protection against genetic discrimination

Genetic predisposition is not equivalent to actual disease, disability, or inability to perform a job. Many genetic traits have probabilistic effects and interact with environmental and social factors.

For example, an employer should not automatically reject an applicant merely because a genetic test indicates an elevated future risk of a particular disease. Any restriction must be assessed under applicable anti-discrimination, employment, privacy, and occupational-safety law.

D. Reproductive autonomy and future generations

Governance must distinguish between different types of genetic intervention:

Heritable genome editing is especially difficult because changes to reproductive cells or embryos may be passed to future generations. UNESCO's genome declaration and subsequent bioethics work emphasize human rights, dignity, rigorous risk assessment, and caution regarding heritable modifications.

UNESCO

+1

4. Important case laws

The following decisions provide judicial foundations for biological inheritance governance. Some directly concern genetic or biological evidence; others establish related principles of privacy, equality, bodily autonomy, and eugenics. They should not be mistaken for decisions recognizing one single, formally named doctrine.

Case 1: Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1

Supreme Court of India · Constitutional privacy

Facts and legal issue: The Supreme Court considered whether privacy is a constitutionally protected right in India in the context of challenges involving the Aadhaar system.

Judgment: A nine-judge Constitution Bench unanimously recognized privacy as a fundamental right protected by the Constitution, particularly under Article 21 and the broader guarantees in Part III.

The judgment established that privacy includes important aspects of personal autonomy, bodily integrity, and informational control. State interference with privacy must satisfy constitutional requirements of legality, legitimate purpose, and proportionality.

Indian Kanoon

Application to biological inheritance governance:

Genetic records can constitute highly sensitive personal information.

Compulsory genetic testing may intrude upon bodily integrity and informational privacy.

Government genetic databases require a valid legal basis and safeguards appropriate to their purpose.

Genetic-data collection should not be broader than reasonably necessary for the legitimate objective pursued.

Legal significance: This is a major constitutional foundation for challenging unjustified collection, disclosure, or use of genetic information in India. It does not, however, establish an absolute prohibition on DNA testing or create a complete, standalone genetic-privacy code.

Case 2: Selvi v. State of Karnataka, (2010) 7 SCC 263

Supreme Court of India · Bodily integrity and compelled scientific techniques

Facts and legal issue: The case concerned the involuntary administration of narcoanalysis, polygraph examinations, and the Brain Electrical Activation Profile test to persons under investigation.

Judgment: The Supreme Court held that involuntary administration of these techniques violated constitutional protections against testimonial compulsion under Article 20(3) and the right to life and personal liberty under Article 21. It also addressed the constitutional and evidentiary consequences of the resulting material.

Application to biological inheritance governance:

The judgment supports the principle that scientific usefulness alone does not justify compelling a person to undergo an intrusive investigative procedure. Compulsory biological testing must be evaluated according to its legal basis, purpose, intrusiveness, and applicable constitutional safeguards.

Legal significance: Although the case did not directly decide the legality of hereditary genetic screening, its reasoning is relevant when governments or investigators seek biological information through coercive methods.

Case 3: Sharda v. Dharmpal, (2003) 4 SCC 493

Supreme Court of India · Court-ordered medical examination

Facts and legal issue: The dispute arose in matrimonial proceedings involving a request for a medical examination. The issue was whether a court has authority to direct a party to undergo medical testing.

Judgment: The Supreme Court recognized that a court may, in appropriate circumstances, order a medical examination when sufficient material justifies it. It rejected the proposition that every such direction necessarily violates personal liberty. The power must be exercised judicially, rather than routinely or arbitrarily.

Application to biological inheritance governance:

The case illustrates the tension between bodily autonomy and the need for reliable evidence in judicial proceedings. Where DNA or genetic testing is sought, the court must consider the relevance of the proposed evidence, the applicable law, privacy interests, and the circumstances justifying the order.

Legal significance: Sharda is not a blanket authorization for compulsory genetic testing. It provides a related procedural principle for judicially supervised medical examinations.

Case 4: Goutam Kundu v. State of West Bengal, (1993) 3 SCC 418

Supreme Court of India · Blood testing and disputed paternity

Facts and legal issue: The case concerned the use of blood-group testing to resolve a dispute about paternity and the circumstances in which a court could order such testing.

Judgment: The Supreme Court cautioned against routinely ordering blood tests in paternity disputes and emphasized the legal presumption of legitimacy under Section 112 of the Indian Evidence Act, 1872, as it then applied. The Court identified safeguards against indiscriminate testing.

Application to biological inheritance governance:

Biological evidence must be considered alongside legal presumptions and the rights of the parties.

A person's biological information should not be obtained merely because testing is technically possible.

Courts must weigh evidentiary necessity against privacy, dignity, and family interests.

Legal significance: The case demonstrates that biological truth and legal parentage are related but distinct concepts. Its historical statutory context must be considered alongside subsequent decisions and the current law of evidence.

Case 5: Bhabani Prasad Jena v. Convenor Secretary, Orissa State Commission for Women, (2010) 8 SCC 633

Supreme Court of India · DNA testing and judicial discretion

Facts and legal issue: The dispute involved a request for DNA testing in proceedings concerning alleged parentage.

Judgment: The Supreme Court held that DNA testing should not be ordered mechanically. Courts must balance the interests of justice and the evidentiary value of the proposed test against privacy, dignity, and other relevant rights.

Application to biological inheritance governance:

This principle is particularly important in genetic disputes. A court should ask whether testing is necessary to resolve a material issue, whether less intrusive evidence is sufficient, and what legal consequences the results may have.

Legal significance: The decision provides a direct Indian judicial reference for the controlled use of biological evidence and the need for proportionality in orders involving genetic or DNA testing.

Case 6: Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013)

Supreme Court of the United States · Genetic material and patent law

Facts: Myriad Genetics identified the location and sequence of the BRCA1 and BRCA2 genes, variants of which can increase the risk of breast and ovarian cancer. The company obtained patents relating to these genes, prompting a challenge to the patentability of naturally occurring DNA.

Judgment: The US Supreme Court held that naturally occurring DNA segments are not patent-eligible merely because they have been isolated from the genome. However, complementary DNA (cDNA) may be patent-eligible because it is not naturally occurring in the same form.

Justia U.S. Supreme Court Center

+1

Application to biological inheritance governance:

Genetic discoveries must be distinguished from genuinely created inventions.

Patent law should not automatically give private entities exclusive rights over naturally occurring human genetic information.

Access to genetic diagnostic technologies may be affected by intellectual-property rules.

Biotechnology innovation must be balanced against public-health interests.

Legal significance: The judgment limits certain forms of genetic patent monopolies under US law. It does not establish that all genetic inventions, diagnostic methods, or biotechnology patents are invalid.

Case 7: Moore v. Regents of the University of California, 51 Cal. 3d 120 (1990)

Supreme Court of California · Human biological materials and informed consent

Facts: John Moore's physician used cells removed during his treatment to develop a commercially valuable cell line without adequately disclosing the physician's research and economic interests.

Judgment: The California Supreme Court allowed claims based on breach of fiduciary duty and lack of informed consent to proceed, but rejected Moore's conversion claim concerning the removed cells.

California Supreme Court Resources

+1

Application to biological inheritance governance:

The case highlights the difference between ownership of biological materials and the right to make informed decisions about their collection and use. Genetic samples, tissues, and derived research materials may generate scientific or commercial value, but the precise legal rights depend on applicable law.

A responsible governance framework should require clear consent, disclosure of material research interests, appropriate oversight, and transparent rules governing secondary use of biological samples.

Legal significance: Moore is influential in debates about biobanks, tissue research, genetic-data commercialization, and benefit-sharing. It does not establish a universal rule that all removed human tissue belongs to the researcher.

Case 8: Buck v. Bell, 274 U.S. 200 (1927)

Supreme Court of the United States · Eugenics and compulsory sterilization

Facts: The case concerned a Virginia law authorizing the compulsory sterilization of certain institutionalized persons classified as genetically unfit.

Judgment: The Supreme Court upheld the sterilization law, accepting the state's eugenic rationale at that time.

Modern legal evaluation: The decision is widely regarded as a notorious example of judicial failure to protect reproductive autonomy and equal human dignity. It must be understood in its historical context, when eugenic ideology influenced public policy and judicial reasoning.

Application to biological inheritance governance:

The case demonstrates the dangers of allowing government authorities to classify individuals as genetically inferior and use that classification to justify coercive reproductive restrictions.

Modern governance should reject the assumption that inherited characteristics establish a person's social worth or justify compulsory sterilization merely to pursue a state's eugenic objectives.

Legal significance: Buck v. Bell is an important cautionary precedent, not an endorsement of modern genetic governance. Its historical survival in US constitutional law does not make eugenic policies ethically legitimate.

5. Comparative legal framework

Biological inheritance governance does not operate identically in every jurisdiction. Its implementation depends on constitutional rights, data-protection rules, biotechnology legislation, and medical regulation.

The table identifies relevant legal foundations, not a claim that each jurisdiction has a comprehensive statute covering every aspect of genetic inheritance.

6. Biological inheritance governance under Indian law

For India, the framework can be developed from constitutional rights, judicial decisions, and legislation regulating personal information, medical research, biotechnology, and discrimination.

A. Constitutional equality under Article 14

Article 14 guarantees equality before the law and equal protection of the laws.

A government policy that classifies people according to hereditary characteristics may require constitutional scrutiny, particularly if the classification is arbitrary or lacks a legitimate and sufficiently justified basis.

For instance, automatically excluding individuals with a hereditary disease risk from a public benefit, without examining the purpose of the benefit or the person's actual circumstances, could raise serious equality concerns.

Article 14 does not prohibit every biological classification. The legality of a particular classification depends on its purpose, rationality, and applicable constitutional standards.

B. Personal liberty under Article 21

Article 21 protects life and personal liberty. Read with Puttaswamy and Selvi, it provides a substantial constitutional foundation for protecting bodily autonomy and genetic privacy.

Potential legal questions include:

Whether compulsory DNA collection is authorized by law.

Whether genetic testing is necessary for the purpose claimed.

Whether the collection and retention of samples are proportionate.

Whether individuals have adequate safeguards against unauthorized disclosure.

Whether genetic information is being used for a purpose different from the one for which it was collected.

C. Data protection and genetic information

The Digital Personal Data Protection Act, 2023, is relevant to digital personal data, subject to its scope, commencement, applicable rules, and exemptions. It should not be assumed to create a complete, standalone regime for genetic information or to apply identically to every biological sample and research activity.

Genetic laboratories, hospitals, and research organizations should examine the applicable consent, notice, security, retention, disclosure, and research requirements rather than relying on a general assumption that all genetic data receive identical legal treatment.

D. Biotechnology and research oversight

Genetic research may also engage applicable biomedical research ethics requirements, institutional review procedures, clinical-trial rules, and biotechnology regulations.

Where research involves human participants, consent and independent ethical review are important safeguards. Research involving genetic modification, embryos, or reproductive interventions may raise additional legal and ethical requirements.

7. Core governance challenges

7.1 Genetic discrimination

A central problem is the use of genetic predisposition as a substitute for individualized assessment.

A person's genetic profile may indicate an increased probability of developing a disease without establishing that the disease will occur. Policies that treat probabilistic information as conclusive evidence of incapacity risk unfairness and discrimination.

Appropriate safeguards include restricted use of genetic information, evidence-based decision-making, and accessible procedures for challenging adverse decisions.

7.2 Intergenerational consent

An adult can consent to an intervention affecting their own body, but cannot obtain direct consent from future descendants who may inherit its consequences.

This creates difficult questions about heritable genome editing. A governance system should require rigorous safety evidence, independent review, transparent authorization, and careful consideration of long-term consequences.

7.3 Biological ownership and commercialization

Biological materials can be used to develop medicines, diagnostic tests, cell lines, and research products. Governance must clarify the rights of donors, researchers, institutions, and commercial entities.

The Moore decision illustrates why informed consent and disclosure are important even when property law does not recognize the patient's ownership claim.

7.4 Genetic information and family relationships

Genetic testing may reveal unexpected parentage or inherited risks affecting relatives. Confidentiality obligations must be balanced against any legally recognized duties to warn or disclose.

Such situations should be handled through applicable law, professional standards, and case-specific assessment, rather than an automatic rule requiring either absolute secrecy or unrestricted disclosure.

8. Proposed institutional governance model

A workable biological inheritance governance framework can be organized around six institutional responsibilities.

1. Consent and authorization

Document the purpose of testing, foreseeable risks, secondary use of samples, and the legal basis for any compulsory procedure.

2. Privacy and security

Restrict access to genetic records, protect research databases, and establish rules for retention, disclosure, and deletion.

3. Equality review

Assess whether decisions based on genetic information are lawful, evidence-based, relevant, and free from unjustified discrimination.

4. Scientific and ethical oversight

Review safety, validity, risks, conflicts of interest, and potential consequences for future generations.

5. Accountability and remedies

Provide independent complaints mechanisms, judicial review where available, corrective action, and remedies under applicable law.

6. Public participation

Include patients, researchers, disability-rights organizations, affected communities, and relevant experts in policy development.

9. Critical analysis

The main difficulty in biological inheritance governance is reconciling competing interests.

First, genetic information can help diagnose disease and prevent harm, but its collection and disclosure may threaten privacy.

Second, biotechnology can produce significant public benefits, but commercial incentives may encourage the exploitation of biological materials or unequal access to treatment.

Third, preventing serious hereditary disease may be a legitimate healthcare objective, but the same language can be misused to justify eugenic policies, coercive sterilization, or discrimination against persons with disabilities.

Fourth, legal systems must protect future generations without treating hypothetical future interests as an unrestricted justification for controlling present-day reproductive decisions.

The appropriate response is neither an absolute prohibition on genetic research nor unrestricted permission to use inherited biological information. Instead, governance should be based on legality, informed consent, scientific evidence, equality, proportionality, transparency, and meaningful accountability.

10. Conclusion

Biological Inheritance Doctrine Governance is best understood as a proposed organizing framework rather than a single established legal doctrine. Its foundations are found in constitutional privacy, equality, bodily autonomy, reproductive rights, medical consent, genetic-data protection, and biotechnology regulation.

The Indian decisions in Puttaswamy, Selvi, Sharda, Goutam Kundu, and Bhabani Prasad Jena offer principles relevant to privacy, bodily integrity, and the judicial use of biological evidence. The comparative cases Myriad Genetics, Moore, and Buck v. Bell illuminate genetic patentability, commercialization of human tissues, and the dangers of eugenic governance.

Taken together, these authorities support a central proposition: inherited biological characteristics may be relevant to legitimate medical and legal decisions, but they should not automatically determine a person's dignity, rights, opportunities, or social status.

The precise legal outcome in any case depends on the jurisdiction, the type of genetic information involved, the purpose for which it is used, and the applicable legislation and judicial precedents.